Table 2.
Patient characteristics (matched cohort analysis)
| Characteristic | Group 1 | Group 2 | P-value/Z value/Effect size |
|---|---|---|---|
| Patient number | 69 | 69 | - |
| Age (median, range; years) | 64 (48–74) | 65 (64–71) | 0.78 |
| Sex (n, %) | |||
| Male | 47 (68.1) | 46 (66.7) | 0.85 |
| Female | 22 (31.9) | 23 (33.3) | |
|
Preoperative urinary catheter (n, %) Of these, patients with ureteral stent | |||
| + |
23 (33.3) 18 (26.1) |
24 (34.8) 15 (21.7) |
0.85 |
| − | 46 (66.7) | 45 (65.2) | |
| Length of postoperative hospital stay (median, range; days) (confidence interval; days) | 4 (3–5) (3.6–4.6) | 3 (3–4) (3.0–5.4) | 0.04*/1.95/0.03 |
| Operative time (median, range; min) | 72 (55–87) | 75 (58–114) | 0.07 |
| Preoperative urine WBC count (median, range; /μL) | 48.0 (8.7–180.0) | 19.4 (6.6–79.1) | 0.15 |
| Preoperative urine bacteria count (median, range; /μL) | 39.2 (8.1–752.0) | 25.0 (10.3–152.0) | 0.38 |
| Preoperative antibiotic treatment (n, %) | 3 (4.3) | 5 (7.2) | 0.71 |
No significant differences between the two groups were found in the primary parameters, except for the postoperative hospital stay duration
CTM Cefotiam, FOM Fosfomycin, WBC White blood cells. The range indicates the minimum and maximum values
* P < 0.05 in the Mann–Whitney U-test